Element of Life ~ Selenium in the Human Body
But several profiles make thorough baseline testing genuinely non-negotiable: Any history of type 2 diabetes or prediabetes (HbA1c monitoring changes medication management) Personal or family history of medullary thyroid carcinoma or MEN2 syndrome (direct contraindication) History of pancreatitis (GLP-1 medications carry a pancreatitis warning) Chronic kidney disease or known renal impairment Current use of insulin, metformin, or other glucose-lowering medications (drug interaction and hypoglycemia risk) History of eating disorders, severe gastroparesis, or significant GI conditions PCOS or other hormonal conditions that drive weight-related metabolic dysfunction 1.3 What clinical guidelines say The American Diabetes Association (ADA) Standards of Medical Care recommend HbA1c, renal function, and lipid panels as part of baseline metabolic assessment before initiating GLP-1 therapy in patients with diabetes
Furthermore, an alternative efficacy assumption was tested by applying treatment effects expressed as incremental differences compared to placebo, derived from the ESSENCE trial, in place of absolute efficacy estimates for semaglutide 2.4 mg
Broad Applicability: Suitable for a variety of injectable drugs as directed by drug manufacturers
Visceral fat, the deep abdominal fat that surrounds internal organs, is far more metabolically active and hormologically disruptive than subcutaneous fat
